Pioglitazone reduces angiotensin II-induced COX-2 expression through inhibition of ROS production and ET-1 transcription in vascular cells from spontaneously hypertensive rats
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pioglitazone reduces angiotensin II-induced COX-2 expression through inhibition of ROS production and ET-1 transcription in vascular cells from spontaneously hypertensive rats
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
Volume 306, Issue 11, Pages H1582-H1593
Publisher
American Physiological Society
Online
2014-04-12
DOI
10.1152/ajpheart.00924.2013
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pioglitazone enhances the blood pressure-lowering effect of losartan via synergistic attenuation of angiotensin II-induced vasoconstriction
- (2013) Xiang Kong et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Effects of PPARγAgonist Pioglitazone on Redox-Sensitive Cellular Signaling in Young Spontaneously Hypertensive Rats
- (2013) Ima Dovinová et al. PPAR Research
- Reciprocal Relationship Between Reactive Oxygen Species and Cyclooxygenase-2 and Vascular Dysfunction in Hypertension
- (2012) Sonia Martínez-Revelles et al. ANTIOXIDANTS & REDOX SIGNALING
- Pioglitazone treatment increases COX-2-derived prostacyclin production and reduces oxidative stress in hypertensive rats: role in vascular function
- (2012) Raquel Hernanz et al. BRITISH JOURNAL OF PHARMACOLOGY
- Endothelin in hypertension
- (2012) Yohann Rautureau et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Pioglitazone ameliorates systolic and diastolic cardiac dysfunction in rat model of angiotensin II-induced hypertension
- (2012) Aiko Sakamoto et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- ET-1 from endothelial cells is required for complete angiotensin II-induced cardiac fibrosis and hypertrophy
- (2012) Suko Adiarto et al. LIFE SCIENCES
- Pioglitazone induces regression and stabilization of coronary atherosclerotic plaques in patients with impaired glucose tolerance
- (2011) H.-B. Yang et al. DIABETIC MEDICINE
- Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension
- (2011) Manuel Gómez-Guzmán et al. FREE RADICAL BIOLOGY AND MEDICINE
- Peroxisome proliferator-activated receptor-γ activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress
- (2011) Angela Martín et al. JOURNAL OF HYPERTENSION
- ETA Activation Mediates Angiotensin II-Induced Infiltration of Renal Cortical T Cells
- (2011) E. I. Boesen et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Role of endothelin in the cardiovascular system
- (2011) Fernando Rodríguez-Pascual et al. PHARMACOLOGICAL RESEARCH
- A Novel and Specific NADPH Oxidase-1 (Nox1) Small-Molecule Inhibitor Blocks the Formation of Functional Invadopodia in Human Colon Cancer Cells
- (2010) Davide Gianni et al. ACS Chemical Biology
- Transcriptional regulation of NADPH oxidase isoforms, Nox1 and Nox4, by nuclear factor-κB in human aortic smooth muscle cells
- (2010) Adrian Manea et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Endothelin-1 gene regulation
- (2010) Lisa R. Stow et al. FASEB JOURNAL
- Oral Intake of Rosiglitazone Promotes a Central Antihypertensive Effect Via Upregulation of Peroxisome Proliferator-Activated Receptor-γ and Alleviation of Oxidative Stress in Rostral Ventrolateral Medulla of Spontaneously Hypertensive Rats
- (2010) Samuel H.H. Chan et al. HYPERTENSION
- Endothelin-1 (ET-1) Increases the Expression of Remodeling Genes in Vascular Smooth Muscle through Linked Calcium and cAMP Pathways
- (2010) Karl Deacon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Impaired Peroxisome Proliferator-activated Receptor-γ Contributes to Phenotypic Modulation of Vascular Smooth Muscle Cells during Hypertension
- (2010) Lili Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Downregulating osteopontin reduces angiotensin II-induced inflammatory activation in vascular smooth muscle cells
- (2009) B. L. Yin et al. INFLAMMATION RESEARCH
- AP-1–Dependent Transcriptional Regulation of NADPH Oxidase in Human Aortic Smooth Muscle Cells
- (2008) Adrian Manea et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The AP-1 site is essential for the promoter activity of NOX1/NADPH oxidase, a vascular superoxide-producing enzyme: Possible involvement of the ERK1/2-JunB pathway
- (2008) Muhammer Ozgur Cevik et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Endothelin: 20 years from discovery to therapyThis article is one of a selection of papers published in the special issue (part 2 of 2) on Forefronts in Endothelin.
- (2008) Matthias Barton et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production
- (2008) S DIKALOV et al. FREE RADICAL BIOLOGY AND MEDICINE
- Uric acid activates extracellular signal-regulated kinases and thereafter endothelin-1 expression in rat cardiac fibroblasts
- (2008) Tzu-Hurng Cheng et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- p38 MAPK contributes to angiotensin II-induced COX-2 expression in aortic fibroblasts from normotensive and hypertensive rats
- (2008) Amada E Beltrán et al. JOURNAL OF HYPERTENSION
- Role of NADPH oxidase and iNOS in vasoconstrictor responses of vessels from hypertensive and normotensive rats
- (2007) Y Álvarez et al. BRITISH JOURNAL OF PHARMACOLOGY
- PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-γ AGONISTS ATTENUATE ANGIOTENSIN II-INDUCED COLLAGEN TYPE I EXPRESSION IN ADVENTITIAL FIBROBLASTS
- (2007) Jia Zhang et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More